Oruka Therapeutics, Inc. (ORKA) stock
Close on Nov 13, 2026Market cap $6.98BP/E –Yield –
Oruka Therapeutics statistics
64 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- –
- Last ex-dividend date
- Aug 29, 2024
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 13, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 5.83
- 2.22
Share statisticsIndustry
- Shares Change (QoQ)
- 10.1%
- 0.49%
- Float
- 35M
- 49M
- Shares Held by Insiders
- 47.7%
- 11.6%
- Shares Held by Institutions
- 112.0%
- 56.4%
Short sellingIndustry
- Short Interest
- 6M
- –
- Short Interest Change
- 5.76%
- -0.80%
- Short % of Float
- 18.7%
- 8.98%
- Short % of Shares Outstanding
- 9.76%
- 6.30%
- Days to Cover
- 7.06
- 5.16
Stock price statisticsIndustry
- 52-Week High
- $115.52
- –
- 52-Week Low
- $25.23
- –
- 20-Day Moving Average
- $94.86
- –
- 50-Day Moving Average
- $89.68
- –
- 200-Day Moving Average
- $72.65
- –
- Average True Range (14)
- $5.66
- –
- Price Change (1 Week)
- 2.42%
- -1.15%
- Price Change (1 Month)
- 42.6%
- -4.86%
- Price Change (3 Months)
- -6.49%
- -21.1%
- Price Change (6 Months)
- 70.1%
- -20.7%
- Price Change (YTD)
- 247.6%
- -23.6%
- Price Change (1 Year)
- 272.3%
- -22.7%
- Price Change (3 Years)
- 398.8%
- -29.5%
- Price Change (5 Years)
- 255.4%
- -77.8%
- Price Change (10 Years)
- -80.3%
- -65.4%
- Average Volume (10 Days)
- 1M
- –
- Average Volume (20 Days)
- 998,113
- –
- Average Volume (90 Days)
- 921,143
- –
- Relative Volume
- 0.74
- 0.70
- Relative Strength Index (14)
- 64.4
- 43.4
- Volatility (1 Year)
- 69.3%
- 80.1%
- Beta (5 Years)
- 0.50
- 1.07
Returns on capitalIndustry
- Return on Equity (ROE)
- -18.1%
- -50.3%
- Return on Assets (ROA)
- -17.5%
- -40.6%
- Return on Invested Capital (ROIC)
- -69.8%
- -33.1%
- Return on Capital Employed (ROCE)
- -15.3%
- -38.0%
Financial positionIndustry
- Current Ratio
- 29.62
- 3.30
- Quick Ratio
- 28.96
- 2.39
EfficiencyIndustry
- Profits Per Employee
- -$2.24M
- -$690.06K
- Employee Count
- 68
- 75
- WACC
- 7.62%
- 10.2%
Income statement (TTM)Industry
Balance sheetIndustry
- Net Cash (Debt)
- $920.28M
- $17.80M
- Net Cash Per Share
- $13.90
- $0.80
- Equity (Book Value)
- $1.20B
- $53.27M
- Book Value Per Share
- $18.08
- $1.50
- Tangible Book Value
- $1.20B
- $26.82M
- Working Capital
- $909.71M
- $79.93M
Cash flow (TTM)Industry
- Capital Expenditures
- -$219.00K
- -$1.00M
- FCF Per Share
- -$1.87
- -$0.42
Dividends and yieldsIndustry
- Earnings Yield
- -2.19%
- -22.0%
- FCF Yield
- -1.78%
- -9.44%
- Buyback Yield
- -0.16%
- -0.76%
- Shareholder Yield
- -0.16%
- 0.00%
Scores and fair valueIndustry
- Altman Z-Score
- 123.59
- 0.23
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | ORKA | S&P 500 | Difference | ORKA per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +34.7% | -3.0% | +37.8 pts | ||
| 3 months | -2.6% | -2.8% | +0.2 pts | ||
| Year to date | +247.6% | +11.5% | +236.1 pts | ||
| 1 year | +299.4% | +13.5% | +285.9 pts | ||
| 3 years | +817.0% | +77.7% | +739.3 pts | +109.3% | +21.1% |
| 5 years | +560.8% | +72.6% | +488.2 pts | +45.9% | +11.5% |
| 10 years | -61.4% | +308.2% | −369.6 pts | -9.1% | +15.1% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
6M ORKA shares were sold short on Oct 30, 2026, up 5.8% from the previous report, or 18.67% of the shares available to trade. At recent volumes it would take 7.1 days to buy them back. Over the last 20 sessions, 53.5% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 6,464,212 | +5.8% | 915,065 | 7.1 |
| Oct 15, 2026 | 6,112,214 | -21.4% | 841,406 | 7.3 |
| Sep 30, 2026 | 7,778,131 | +2.0% | 1,230,336 | 6.3 |
| Sep 15, 2026 | 7,623,327 | -2.2% | 656,686 | 11.6 |
| Aug 31, 2026 | 7,793,678 | -6.1% | 840,475 | 9.3 |
| Aug 14, 2026 | 8,303,245 | +3.1% | 732,736 | 11.3 |
| Jul 31, 2026 | 8,051,704 | -8.8% | 961,164 | 8.4 |
| Jul 15, 2026 | 8,833,223 | -3.6% | 1,415,114 | 6.2 |
| Jun 30, 2026 | 9,160,848 | +32.8% | 2,137,020 | 4.3 |
| Jun 15, 2026 | 6,896,890 | +8.2% | 1,134,408 | 6.1 |
| May 29, 2026 | 6,373,113 | +1.9% | 1,283,135 | 5.0 |
| May 15, 2026 | 6,251,854 | -10.6% | 1,750,171 | 3.6 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?